WAVwatch 2.0 wearable sound device to help reduce everyday stress
Official title: Sound Stops Stress Study: Evaluating the WAVwatch Effect
Run by Efforia, Inc · NCT07281989 · Data updated 2026-11-12
This remote study will test whether wearing the WAVwatch 2.0 sound-frequency device can reduce stress and everyday anxiety for English-speaking adults living in the U.S.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Efforia, Inc Industry-sponsored |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | August 25, 2025 |
| Main results expected | August 25, 2026 |
| Study ends | August 25, 2026 |
| Registry record updated | December 23, 2025 |
| Trial ID | NCT07281989 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-literate adults in the U.S. without skin or auditory sensitivities, who are not pregnant and do not have severe anxiety or other serious mental health disorders.
✕Probably not a fit
People with skin or ear sensitivities, auditory conditions, pregnancy, severe anxiety or other major mental health disorders, or those who become easily irritated by the device are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This decentralized, remotely administered trial asks participants to use the WAVwatch 2.0, a wearable that delivers targeted sound frequencies, and report changes in stress and anxiety. Participants will be screened for basic eligibility (U.S. resident, English literacy) and exclusions such as skin sensitivities, auditory conditions, pregnancy, or severe mental health disorders. Outcomes will focus on self-reported stress and anxiety measures and overall life satisfaction, with participants receiving personalized feedback on their results. The trial aims to provide data-driven information about whether the device produces measurable short-term changes in well-being.
Why it matters
Potential benefit: If successful, the device could offer a non-drug, wearable option for people seeking to reduce everyday stress and improve wellbeing.
How similar studies have gone: Sound-based and frequency therapies have some small, mixed studies suggesting possible benefits but robust, large-scale randomized evidence is limited, so this approach remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Can read and understand English. * US resident. * Willing and able to follow the requirements of the protocol. Exclusion Criteria: * Individuals with skin sensitivities * Individuals with auditory conditions * Individuals with severe anxiety or mental health disorders * Pregnancy * Individuals prone to irritation or frustration
Where it's running
-
Efforia
New York, New York, United States Recruiting
Study contacts
- Study coordinator: Matthew Amsden
- Email: help@efforia.com
- Phone: 646-679-2479
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers
This study tests whether oxidative stress linked to Nox2 is related to dementia risk in adults with type 2 diabetes.
-
Opioid-Free vs Opioid-Based Anesthesia for Thyroid Surgery
This study tests whether a non-opioid anesthesia approach can match or improve outcomes for adults undergoing thyroidectomy.
-
Training to reduce oxidative stress in knee OA
A six-week program compares supervised knee-strengthening training with a daily 6,000-step walking plan to see if it improves pain, function, and blood markers of cellular stress in people with knee osteoarthritis.
-
Ashwagandha with resistance training to boost strength and stress markers
This 12-week study tests whether taking ASHWAGANDHA along with regular resistance training helps healthy, trained men see improvements in strength, stress levels, sleep, and cognitive function compared with a placebo.
-
Oxidative Stress and Heart Risk in People with Rheumatoid Arthritis
This study tests whether certain markers of oxidative stress in people with rheumatoid arthritis are linked to subclinical atherosclerosis and arterial stiffness, which could relate to future heart disease risk.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.